Cancer

News

GSK's chairman Sir Philip Hampton steps down

GlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in the wake of the company’s split into two businesses.

News

Lilly stops promoting cancer drug after shock trial failure

Shares in Eli Lilly were down in early trading after the US drugmaker said its cancer drug Lartruvo failed to meet main survival goals in a late stage trial, prompting the company to stop p

News

Known as Cabometyx in the US, the drug is licensed by Ipsen from Exelixis

Exelixis' Cabometyx approved in second-line liver cancer in ...

Exelixis’ cancer drug Cabometyx has been approved in a new liver cancer use in the US, providing a second line therapy option for patients previously treated with Bayer’s Nexavar.<

News

Lilly's CEO looks to M&A, but not for CAR-T or gene therapie...

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others

News

Liquid biopsy-based system could prevent cancer from spreadi...

Angle’s liquid biopsy system has been used in new cancer research that could provide a novel way to treat breast cancer and other tumours, by stopping or suppressing their spread from the o

News

UroGen's urothelial cancer drug hits target, could prevent s...

Former Novartis oncology chief Liz Barrett’s decision to jump ship to lead the biotech UroGen appears to have been vindicated after the company announced top-line results showing its lead d

GSK's chairman Sir Philip Hampton steps down

Lilly stops promoting cancer drug after shock trial failure

Exelixis' Cabometyx approved in second-line liver cancer in ...

Lilly's CEO looks to M&A, but not for CAR-T or gene therapie...

Liquid biopsy-based system could prevent cancer from spreadi...

UroGen's urothelial cancer drug hits target, could prevent s...

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Cancer

Editor's Picks